neurodevelopmental

SpeechATAXIA is a multi-language, multi-national, multi-ataxia consortia designed to measure communication change over time.

Redenlab are proud to support an upcoming randomized parallel group, placebo-controlled, dose-escalation clinical trial in Ataxia Telangiectasia

Redenlab Inc. are excited to announce securing another clinical trial in Friedreich ataxia. Redenlab are providing speech analytics…

Redenlab Inc, the speech neuroscience company delivering insights in communication testing, announces that it has been selected by…

Redenlab are proud to be supporting PTC Therapeutics, Inc. Global Phase 3 Clinical Trial to Evaluate Vatiquinone in…

Redenlab has entered into a 5 year collaboration with investigators from North and South America, Australia and Europe…

BackgroundSubmucous cleft palate (SMCP) has a heterogeneous presentation and is often identified late or misdiagnosed. Diagnosis is prompted…